Applications of single-cell and bulk RNA sequencing in onco-immunology

Eur J Cancer. 2021 May:149:193-210. doi: 10.1016/j.ejca.2021.03.005. Epub 2021 Apr 15.

Abstract

The rising interest for precise characterization of the tumour immune contexture has recently brought forward the high potential of RNA sequencing (RNA-seq) in identifying molecular mechanisms engaged in the response to immunotherapy. In this review, we provide an overview of the major principles of single-cell and conventional (bulk) RNA-seq applied to onco-immunology. We describe standard preprocessing and statistical analyses of data obtained from such techniques and highlight some computational challenges relative to the sequencing of individual cells. We notably provide examples of gene expression analyses such as differential expression analysis, dimensionality reduction, clustering and enrichment analysis. Additionally, we used public data sets to exemplify how deconvolution algorithms can identify and quantify multiple immune subpopulations from either bulk or single-cell RNA-seq. We give examples of machine and deep learning models used to predict patient outcomes and treatment effect from high-dimensional data. Finally, we balance the strengths and weaknesses of single-cell and bulk RNA-seq regarding their applications in the clinic.

Keywords: Bulk RNA-seq; Cancer; Immunotherapy; Precision medicine; Single-cell RNA-seq; Tumour microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Artificial Intelligence
  • Biomarkers, Tumor / genetics*
  • Clinical Decision-Making
  • Gene Expression Profiling*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / genetics*
  • Neoplasms / immunology*
  • Neoplasms / pathology
  • Precision Medicine
  • Predictive Value of Tests
  • Prognosis
  • RNA, Neoplasm / genetics*
  • RNA-Seq*
  • Single-Cell Analysis*
  • Transcriptome*
  • Tumor Microenvironment / immunology*

Substances

  • Biomarkers, Tumor
  • RNA, Neoplasm